Embera NeuroTherapeutics, Inc. Announces Expansion of Management Team after Successful Completion of Pilot Study of Cocaine Addiction Treatment
7/20/2009 10:22:09 AM
SHREVEPORT, La.--(BUSINESS WIRE)--Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug addiction and obesity, announced today that the company has recently expanded its management team to prepare for its next stage of development, following the successful completion of the company’s pilot study of cocaine addiction treatment.
comments powered by